SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-21-026918
Filing Date
2021-11-02
Accepted
2021-11-01 19:38:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc-13d.htm SC 13D 109094
  Complete submission text file 0001493152-21-026918.txt   110747
Mailing Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140
Business Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140 (305) 204-3338
SAB Biotherapeutics, Inc. (Subject) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92283 | Film No.: 211368774
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140
Business Address 300 W. 41ST STREET SUITE 202 MIAMI BEACH FL 33140 (305) 204-3338
Big Cypress Holdings LLC (Filed by) CIK: 0001833242 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D